INTERLEUKIN-2 IN THERAPY OF HEMATOLOGIC MALIGNANCIES

被引：0
|
作者：
SZNOL, M [1 ]
PARKINSON, DR [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,CANC THERAPY EVALUAT PROGRAM,INVEST DRUG BRANCH,EPN 715,ROCKVILLE,MD 20852
来源：
BLOOD | 1994年 / 83卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2020 / 2022
页数：3
相关论文
共 50 条
  • [1] THE ROLE OF RECOMBINANT INTERLEUKIN-2 IN THERAPY FOR HEMATOLOGIC MALIGNANCIES
    DUTCHER, JP
    WIERNIK, PH
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 33 - 40
  • [2] Interleukin-2 in the treatment of hematologic malignancies
    Fefer, A
    CANCER JOURNAL, 2000, 6 : S31 - S32
  • [3] Interleukin-2 in the treatment of hematologic malignancies
    Fefer, A
    CANCER JOURNAL, 1997, 3 : S35 - S36
  • [4] Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies
    Fefer, A
    Robinson, N
    Benyunes, MC
    Bensinger, WI
    Press, O
    Thompson, JA
    Lindgren, C
    CANCER JOURNAL, 1997, 3 : S48 - S53
  • [5] INTERLEUKIN-2 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    FEFER, A
    BENYUNES, MC
    MASSUMOTO, C
    HIGUCHI, C
    YORK, A
    BUCKNER, CD
    THOMPSON, JA
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 41 - 45
  • [6] Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignancies
    Nichols, J
    Foss, F
    Kuzel, TM
    LeMaistre, CF
    Platanias, L
    Ratain, MJ
    Rook, A
    Saleh, M
    Schwartz, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : S34 - S36
  • [7] TOXICITY AND IMMUNOMODULATORY EFFECTS OF INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    HIGUCHI, CM
    THOMPSON, JA
    PETERSEN, FB
    BUCKNER, CD
    FEFER, A
    BLOOD, 1991, 77 (12) : 2561 - 2568
  • [8] Role of interleukin-2 in human hematological malignancies
    Toren, A
    Ackerstein, A
    Slavin, S
    Nagler, A
    MEDICAL ONCOLOGY, 1995, 12 (03): : 177 - 186
  • [9] Interleukin-2 (IL-2) as a consolidative treatment after autologous bone marrow transplantation for hematologic malignancies.
    Massumoto, C
    Ostronoff, M
    Macedo, MCMA
    ZAmbon, E
    Medeiros, RSS
    DorlhiacLlacer, PE
    Chamone, DAF
    Dulley, F
    BLOOD, 1995, 86 (10) : 3817 - 3817
  • [10] INTERLEUKIN-2 IN ANTICANCER THERAPY
    HERRERA, A
    PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 1075 - 1076
12345